IGNT

Replies to This Discussion

Permalink Reply by benji_royale on November 3, 2009 at 10:15am

i have a good feeling about this one but i think its a long hold

▶ Reply to This

Permalink Reply by mickymoose99 on November 21, 2009 at 5:12pm

Ingen Enters Hospital and Therapy Markets With Expected Revenue Increase


CEO Live Radio Broadcast Talks About These New Markets
YUCAIPA, Calif., Nov 20, 2009 (GlobeNewswire via COMTEX) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the company is now marketing direct to the hospital and therapy respiratory markets. Ingen's CEO, Scott Sand, will discuss these new markets this coming Tuesday, November 24, 2009 at 11:34AM eastern standard time on The Money Channel's American Scene Radio with host Steve Crowley.
According to the most recent report published in June 2009 and made available on the Global Market Research Information Network, respiratory market revenues are high currently, with good potential for sales increases. As the patient population grows and respiratory diseases become more prevalent, the market has the potential for continued growth in many countries and therapeutic areas. There is a great demand for products that provide therapeutic and commercial benefits in this demanding and competitive market. The developing markets of Asia, Latin America and Europe will drive sales increases in particular.

The company is introducing its new Oxyview Nasal Cannula at the America Association of Respiratory Care (AARC) on December 5 - 7, 2009 as an exhibitor. There are 47,000 members of AARC who are hospital based clinicians, therapists and managers, and a large majority will be attending this annual meeting in San Antonio, Texas.

"Our focus has been home health care markets and this is going very smoothly with an increase in sales from home oxygen patients and oxygen providers. Our GSA application is expected to be approved in the near future, and with the growing hospital markets in respiratory care, the Oxyview Nasal Cannula will be an attractive device for hospital nursing as it has shown to save time and provide additional assurance of oxygen flow. Our near final ISO Certification expected in late December 2009 and our recent issue/publication of our patent in the People's Republic of China is in alignment with the future demand for our Oxyview Nasal Cannula in various export countries according to the most recent studies," stated Scott Sand, Chief Executive Officer and Chairman of the Board.

http://www.electronics-ca.com/products/World-Respiratory-Disorders-...

http://www.moneychannel.tv/scas.php

http://www.aarc.org/

http://www.medox-oxyview.com/

www.ingen-tech.com

About Ingen: Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations and OEM partners. In 2009, the company introduced the new Oxyview Nasal Cannula for adult, children and infants, with issued patents in China and the USA, and pending patents in Japan, Canada and European Communities expected to be issued in 2010. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.

▶ Reply to This

Permalink Reply by Rusty Rollanarie on January 6, 2010 at 8:55am

Press Release on IGNT,

IGNT and Amsino International Sign Supply Agreement
Click Here to Read the Featured Report about this Company

YUCAIPA, Calif., Jan. 5, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News ), a leading global Medical Device Manufacturer for the Oxyview Nasal Cannula, focused on the $4B Respiratory market for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that they have signed a Supply Agreement with Amsino International Inc. on December 1, 2009.

The Pomona-California based Amsino was established in 1993 and is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. Amsino's product and service portfolio includes infusion products and access devices, blood collection and transfusion devices, anesthesia and surgical products, urological products, enteral feeding and irrigation products, respiratory therapy products, patient care products, and a full-service contract manufacturing business. Amsino products are distributed in the United States and more than 30 other countries worldwide.

Ingen and Amsino will manufacture the Oxyview and Oxyview Nasal Cannula at a reduced cost compared to current manufacturing costs. The Supply Agreement is effective for a 3-year term and is renewable.

Ingen is ready for ISO 13485 Certification and is now waiting in line for an audit date in January-2010. The company expects to be certified and the CE Mark and distribution of product will follow. The company expects GSA approval and will make an announcement in January. Both ISO certification and GSA will expand product distribution to U.S. Government branches, inclusive of the Department of Defense and the VA Hospital network, as well as export to China, Japan, Canada, Australia and Europe.

"We look forward to working with Richard Lee, CEO of Amsino, and his professional team. This agreement allows Ingen to reduce manufacturing costs by 40%, and increase efficiency and quality of our respiratory product line. Amsino International was introduced to us through Pacific Pearl Group, our Investment Banking consultants, who have evaluated Amsino as a good fit for manufacturing and distribution of the Ingen product line. With ISO certification near completion and GSA close to approval, the relationship between Amsino and Ingen is expected to be a prosperous one," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.

Watch the charts today, expecting a green finish!

▶ Reply to This

Permalink Reply by anthonymidwood on November 23, 2009 at 11:36am

I was over looking the charts this morning and the pattern indicates it could head upward, obviously just IMO but still it would be a smart idea to keep an eye on. The company produces extremely important respirsatory devices which are always in high demand; people need them every day. I'm pretty confident the company will create high revenue and profit for people such as myself and you!!!

▶ Reply to This

Permalink Reply by mickymoose99 on November 23, 2009 at 1:57pm

IGNT

Right now the is gap is 27 X 29

Bids are building @.0027 5 x 3

+ 3.57 % recovering from the dip earlier today

RSI LINE @ 46.97 and starting to rise

HIST GRAM starting to build

SLOPE is also starting to rise

With IGNT entering the hospital and therapy markets

I believe its only a matter of time before we see IGNT

Take off ,

▶ Reply to This

Permalink Reply by mickymoose99 on November 23, 2009 at 6:58pm

Photo Release -- Ingen at Home Plate Ready to Catch Sales of $10M in 2010 and $50M in 2012

YUCAIPA, Calif., Nov 23, 2009 (GlobeNewswire via COMTEX) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries announced today that expected sales projections for 2010 and 2012 are on target.
Photos accompanying this release are available at http://www.globenewswire.com/newsroom/prs/?pkgid=6868 and http://www.globenewswire.com/newsroom/prs/?pkgid=6869

The company's ISO Certification in December 2009 also allows Ingen to begin shipping product of its new Oxyview Nasal Cannula and Oxyview to China, Europe, Australia, Japan and Canada. Export sales will represent the majority of our $10M in 2010, and by 2012 reach $50M.The company's ISO consultant, Emergo Consulting Group, is assisting with both the ISO and CE Mark, as well as introducing these products to their distribution partners for export in these countries.

In addition to ISO Certification, the company expects to have in place its GSA contract with various government sectors including VA Hospitals and the Department of Defense in 3-4 weeks.

"Emergo Consulting Group will provide us with the outcome of the MEDICA exhibit in Germany, and this will be provided in a news release later this week. The Oxyview Nasal Cannula has received serious interest from institutional buyers, oxygen providers and suppliers, and patients. Sales have been made to all of these sectors in the past 2 months, and interest continues to grow," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.

http://www.moneychannel.tv/scas.php

http://www.swivel.com/data_sets/show/1016323

http://www.copd-international.com/library/statistics.htm

▶ Reply to This

Permalink Reply by rob steinhauser on January 6, 2010 at 2:26pm

IGNT news was awesome. They signed a 3 year supply aggrement with Amsino. With these two comapnies working together will reduce the manufacturing cost by 40%. As I am watching this stock move today I expect a great run today and the rest of the week. Charts show the stock is on a uptrend and price has broken through the 8,20,50 day moving avgs. Stock is now bullish @56.69 and heading north to power. This nis the perfect time to load up on this one and swing trade this one!!!!

▶ Reply to This

Permalink Reply by rob steinhauser on January 14, 2010 at 12:44pm

IGNT Off to a slow start this morning. Stock is bearish right now but with this news that came out on the stock this morning I expect this stock to bounce back this afternoon and tmw. I also think today the stock will push through .25 and .26 today and see more apprecation tmw. I personally am playing this as a swing trade. Remember to do ur own research and this is strictly my opinion

▶ Reply to This